Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
52
CYCN Quote, Financials, Valuation and Earnings
Last price:
$3.24
Seasonality move
:
-0.35%
Day range:
$2.83 - $3.43
52-week range:
$1.27 - $9.47
Dividend yield:
0%
P/E ratio:
3.20x
P/S ratio:
--
P/B ratio:
1.05x
Volume:
262.9K
Avg. volume:
6.5M
1-year change:
-24.94%
Market cap:
$8.6M
Revenue:
--
EPS (TTM):
-$2.14
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.5M | $2.3M | $3.3M | $297K | -- | |
| Revenue Growth (YoY) | -- | -49.06% | 44.6% | -91.05% | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $95.1M | $56.4M | $37.6M | $6M | $1.5M | |
| Selling, General & Admin | $34.4M | $28.8M | $20.6M | $12.9M | $8.1M | |
| Other Inc / (Exp) | -- | $4.5M | $2.7M | -- | -$3.3M | |
| Operating Expenses | $129.5M | $85.2M | $57.6M | $18.8M | $9.6M | |
| Operating Income | -$125M | -$82.9M | -$54.3M | -$18.5M | -$9.6M | |
| Net Interest Expenses | -- | -- | $16K | -- | -- | |
| EBT. Incl. Unusual Items | -$123M | -$77.8M | -$51.6M | -$18.2M | -$12.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -$25.8M | $7.3M | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$123M | -$77.8M | -$51.6M | -$44.1M | -$5.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$123M | -$77.8M | -$51.6M | -$44.1M | -$5.3M | |
| Basic EPS (Cont. Ops) | -$89.80 | -$51.20 | -$26.40 | -$20.28 | -$2.25 | |
| Diluted EPS (Cont. Ops) | -$89.80 | -$51.20 | -$26.40 | -$20.28 | -$2.25 | |
| Weighted Average Basic Share | $1.4M | $1.5M | $2M | $2.2M | $2.3M | |
| Weighted Average Diluted Share | $1.4M | $1.5M | $2M | $2.2M | $2.3M | |
| EBITDA | -$122.3M | -$80.6M | -$53.8M | -$18.5M | -$9.6M | |
| EBIT | -$125M | -$82.9M | -$54.3M | -$18.5M | -$9.6M | |
| Revenue (Reported) | $4.5M | $2.3M | $3.3M | $297K | -- | |
| Operating Income (Reported) | -$125M | -$82.9M | -$54.3M | -$18.5M | -$9.6M | |
| Operating Income (Adjusted) | -$125M | -$82.9M | -$54.3M | -$18.5M | -$9.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $400K | $77K | -- | -- | $194K | |
| Revenue Growth (YoY) | -71.39% | -80.75% | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $13.7M | $7M | $1.4M | $580K | $81K | |
| Selling, General & Admin | $8M | $4.6M | $3.1M | $2.1M | $1.2M | |
| Other Inc / (Exp) | $2.4M | -- | -- | -$3.3M | $363K | |
| Operating Expenses | $21.7M | $11.4M | $4.5M | $2.7M | $1.3M | |
| Operating Income | -$21.3M | -$11.3M | -$4.5M | -$2.7M | -$1.1M | |
| Net Interest Expenses | -- | $5K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$18.8M | -$11.3M | -$4.4M | -$5.9M | -$723K | |
| Earnings of Discontinued Ops. | -- | -- | -$6.1M | $13.5M | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$18.8M | -$11.3M | -$10.5M | $7.6M | -$723K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$18.8M | -$11.3M | -$10.5M | $7.6M | -$723K | |
| Basic EPS (Cont. Ops) | -$11.80 | -$5.20 | -$4.83 | $3.10 | -$0.29 | |
| Diluted EPS (Cont. Ops) | -$11.80 | -$5.20 | -$4.83 | $2.72 | -$0.29 | |
| Weighted Average Basic Share | $1.6M | $2.2M | $2.2M | $2.4M | $2.5M | |
| Weighted Average Diluted Share | $1.6M | $2.2M | $2.2M | $2.8M | $2.5M | |
| EBITDA | -$20.7M | -$11.2M | -$4.5M | -$2.7M | -$1.1M | |
| EBIT | -$21.3M | -$11.3M | -$4.5M | -$2.7M | -$1.1M | |
| Revenue (Reported) | $400K | $77K | -- | -- | $194K | |
| Operating Income (Reported) | -$21.3M | -$11.3M | -$4.5M | -$2.7M | -$1.1M | |
| Operating Income (Adjusted) | -$21.3M | -$11.3M | -$4.5M | -$2.7M | -$1.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3.6M | $3.3M | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $65M | $39.3M | $31.8M | $2.7M | $254K | |
| Selling, General & Admin | $28.9M | $23.5M | $15M | $9.6M | $5.9M | |
| Other Inc / (Exp) | $4.5M | -$881K | $3.6M | -$3.3M | $363K | |
| Operating Expenses | $93.9M | $62.5M | $45.8M | $12.3M | $6.1M | |
| Operating Income | -$90.3M | -$59.2M | -$45.3M | -$12.3M | -$5.9M | |
| Net Interest Expenses | -- | $19K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$84.6M | -$60.1M | -$41.5M | -$15.2M | -$5.3M | |
| Earnings of Discontinued Ops. | -- | -- | -$6.1M | $4.4M | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$84.6M | -$60.1M | -$47.6M | -$10.8M | -$5.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$84.6M | -$60.1M | -$47.6M | -$10.8M | -$5.3M | |
| Basic EPS (Cont. Ops) | -$59.40 | -$33.00 | -$21.79 | -$5.25 | -$2.14 | |
| Diluted EPS (Cont. Ops) | -$59.40 | -$33.00 | -$21.79 | -$5.63 | -$2.14 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$87.8M | -$58.3M | -$45.2M | -$12.3M | -$5.9M | |
| EBIT | -$90.3M | -$59.2M | -$45.3M | -$12.3M | -$5.9M | |
| Revenue (Reported) | $3.6M | $3.3M | -- | -- | -- | |
| Operating Income (Reported) | -$90.3M | -$59.2M | -$45.3M | -$12.3M | -$5.9M | |
| Operating Income (Adjusted) | -$90.3M | -$59.2M | -$45.3M | -$12.3M | -$5.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2M | $3.1M | $297K | -- | $194K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $44.3M | $27.2M | $21.4M | $1.5M | $230K | |
| Selling, General & Admin | $21.6M | $16.2M | $10.6M | $6.4M | $4.1M | |
| Other Inc / (Exp) | $4.5M | -$881K | -- | -$3.3M | $363K | |
| Operating Expenses | $65.9M | $43.1M | $31.2M | $7.9M | $4.3M | |
| Operating Income | -$63.7M | -$40M | -$30.9M | -$7.9M | -$4.1M | |
| Net Interest Expenses | -- | $15K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$58.6M | -$40.9M | -$30.8M | -$10.9M | -$3.6M | |
| Earnings of Discontinued Ops. | -- | -- | -$6.1M | $7.3M | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$58.6M | -$40.9M | -$36.9M | -$3.6M | -$3.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$58.6M | -$40.9M | -$36.9M | -$3.6M | -$3.6M | |
| Basic EPS (Cont. Ops) | -$40.40 | -$22.00 | -$16.99 | -$1.93 | -$1.44 | |
| Diluted EPS (Cont. Ops) | -$40.40 | -$22.00 | -$16.99 | -$2.31 | -$1.44 | |
| Weighted Average Basic Share | $4.4M | $5.7M | $6.5M | $6.9M | $7.5M | |
| Weighted Average Diluted Share | $4.4M | $5.7M | $6.5M | $7.2M | $7.5M | |
| EBITDA | -$61.9M | -$39.6M | -$30.9M | -$7.9M | -$4.1M | |
| EBIT | -$63.7M | -$40M | -$30.9M | -$7.9M | -$4.1M | |
| Revenue (Reported) | $2.2M | $3.1M | $297K | -- | $194K | |
| Operating Income (Reported) | -$63.7M | -$40M | -$30.9M | -$7.9M | -$4.1M | |
| Operating Income (Adjusted) | -$63.7M | -$40M | -$30.9M | -$7.9M | -$4.1M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $94.9M | $54.4M | $54M | $13.4M | $7.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.5M | $127K | $100K | $96K | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $2M | $816K | $928K | $805K | $442K | |
| Other Current Assets | $2.9M | $3.2M | $468K | $537K | $11K | |
| Total Current Assets | $101.2M | $58.5M | $55.5M | $14.8M | $8M | |
| Property Plant And Equipment | $79.8M | $50.3M | $1.5M | $1.2M | -- | |
| Long-Term Investments | -- | -- | -- | -- | $5.4M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $5.5M | $6.6M | $2.4M | $2M | -- | |
| Total Assets | $186.5M | $115.4M | $59.3M | $18.1M | $13.4M | |
| Accounts Payable | $3.3M | $1.4M | $1.8M | $3M | $1.2M | |
| Accrued Expenses | $4.4M | $2.6M | $7M | $3.4M | $786K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $3.4M | $3.3M | -- | -- | -- | |
| Other Current Liabilities | $404K | $176K | $526K | $68K | $102K | |
| Total Current Liabilities | $18.2M | $17M | $11.1M | $7.6M | $2.1M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $88.7M | $55.9M | $11.1M | $7.6M | $2.1M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -$20K | -$27K | -$23K | -$20K | -$12K | |
| Common Equity | $97.7M | $59.5M | $48.2M | $10.5M | $11.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $97.7M | $59.5M | $48.2M | $10.5M | $11.3M | |
| Total Liabilities and Equity | $186.5M | $115.4M | $59.3M | $18.1M | $13.4M | |
| Cash and Short Terms | $94.9M | $54.4M | $54M | $13.4M | $7.6M | |
| Total Debt | -- | $3.5M | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $66.8M | $62.5M | $20.4M | $9.1M | $2.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $400K | $158K | $227K | -- | $44K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $1.2M | $562K | $536K | $726K | $621K | |
| Other Current Assets | $1.7M | $459K | $488K | $30K | $11K | |
| Total Current Assets | $70.1M | $63.7M | $21.7M | $9.9M | $3.5M | |
| Property Plant And Equipment | $54.6M | $1.6M | $1.3M | -- | -- | |
| Long-Term Investments | -- | -- | -- | $5.4M | $5.4M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $6.7M | $2.5M | $2.1M | -- | -- | |
| Total Assets | $131.4M | $67.7M | $25.1M | $15.2M | $8.9M | |
| Accounts Payable | $1.9M | $1.2M | $1.6M | $814K | $304K | |
| Accrued Expenses | $4.1M | $4.4M | $5.4M | $1.1M | $353K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $3.1M | -- | -- | -- | -- | |
| Other Current Liabilities | $343K | $833K | $159K | $158K | $43K | |
| Total Current Liabilities | $16.3M | $11.4M | $8.5M | $2.3M | $700K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $56M | $11.4M | $8.5M | $2.3M | $700K | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -$27K | -$26K | -$28K | -$18K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $75.4M | $56.4M | $16.5M | $12.9M | $8.2M | |
| Total Liabilities and Equity | $131.4M | $67.7M | $25.1M | $15.2M | $8.9M | |
| Cash and Short Terms | $66.8M | $62.5M | $20.4M | $9.1M | $2.9M | |
| Total Debt | $3.5M | $3.5M | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$123M | -$77.8M | -$51.6M | -$44.1M | -$5.3M | |
| Depreciation & Amoritzation | $2.7M | $2.3M | $472K | $65K | -- | |
| Stock-Based Compensation | $19.6M | $15M | $9.6M | $6.3M | $1.1M | |
| Change in Accounts Receivable | -$1.5M | $1.3M | $27K | $4K | $96K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$102.2M | -$72.5M | -$36.5M | -$40.6M | -$21.2M | |
| Capital Expenditures | $6.9M | $1.5M | $7K | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6.7M | $18K | $1.5M | -- | $10.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $3.5M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $36.1M | -- | -- | -- | -- | |
| Cash From Financing | $211.6M | $28.1M | $30.8M | $29K | $5M | |
| Beginning Cash (CF) | -- | $102.6M | $58.2M | $54M | $13.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $102.6M | -$44.4M | -$4.3M | -$40.6M | -$5.8M | |
| Ending Cash (CF) | $102.6M | $58.2M | $54M | $13.4M | $7.6M | |
| Levered Free Cash Flow | -$109.1M | -$74M | -$36.5M | -$40.6M | -$21.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$18.8M | -$11.3M | -$10.5M | $7.6M | -$723K | |
| Depreciation & Amoritzation | $588K | $48K | -- | -- | -- | |
| Stock-Based Compensation | $3.8M | $2.4M | $1.7M | $159K | $138K | |
| Change in Accounts Receivable | $351K | -$158K | -- | -- | -$44K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$15M | -$7.9M | -$9.9M | -$6.9M | -$1.7M | |
| Capital Expenditures | $9K | $7K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $3K | -$7K | -- | $10.4M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $24.3M | $43K | -- | -- | -- | |
| Beginning Cash (CF) | $61.5M | $70.4M | $30.3M | $5.6M | $4.6M | |
| Foreign Exchange Rate Adjustment | $3K | -- | -$3K | -- | -- | |
| Additions / Reductions | $9.2M | -$7.9M | -$9.9M | $3.5M | -$1.7M | |
| Ending Cash (CF) | $70.7M | $62.5M | $20.4M | $9.1M | $2.9M | |
| Levered Free Cash Flow | -$15.1M | -$7.9M | -$9.9M | -$6.9M | -$1.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$84.6M | -$60.1M | -$47.6M | -$10.8M | -$5.3M | |
| Depreciation & Amoritzation | $2.5M | $894K | $113K | -- | -- | |
| Stock-Based Compensation | $16.3M | $10.3M | $7.7M | $2.1M | $606K | |
| Change in Accounts Receivable | $1M | $241K | -$69K | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$80.6M | -$41.9M | -$42.2M | -$26.7M | -$6.2M | |
| Capital Expenditures | $1.7M | $42K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.5M | $2.9M | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $28.1M | $30.9M | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$54.1M | -$8.2M | -$42.1M | -$11.3M | -$6.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$82.3M | -$42M | -$42.2M | -$26.7M | -$6.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$58.6M | -$40.9M | -$36.9M | -$3.6M | -$3.6M | |
| Depreciation & Amoritzation | $1.8M | $424K | $65K | -- | -- | |
| Stock-Based Compensation | $11.8M | $7.1M | $5.1M | $964K | $503K | |
| Change in Accounts Receivable | $1.1M | -$31K | -$127K | $96K | -$44K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$58.4M | -$27.9M | -$33.6M | -$19.7M | -$4.7M | |
| Capital Expenditures | $1.5M | $7K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.4M | $1.5M | -- | $10.4M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $3.5M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $27.9M | $30.7M | $17K | $5M | -- | |
| Beginning Cash (CF) | $236.2M | $173.9M | $125.4M | $26.2M | $17.9M | |
| Foreign Exchange Rate Adjustment | -$7K | $1K | -$5K | $4K | -$6K | |
| Additions / Reductions | -$31.9M | $4.3M | -$33.6M | -$4.3M | -$4.7M | |
| Ending Cash (CF) | $204.2M | $178.2M | $91.9M | $21.9M | $13.2M | |
| Levered Free Cash Flow | -$59.9M | -$27.9M | -$33.6M | -$19.7M | -$4.7M | |
Get CYCN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CYCN
Sector
P/E ratio
3.20x
25.86x
PEG ratio
--
0.00x
P/B ratio
1.05x
1.85x
Price / LTM sales
--
1.86x
Growth Metrics
CYCN
Sector
Revenue growth
--
7.28%
Earnings growth
--
1.82%
Revenue (5-year growth)
--
8.73%
Earnings forecast
--
-$0.20
Profitability
CYCN
Sector
Profitability FY 2024
--
$57.1M
Return on invested capital
-51.71%
-14.06%
Return on assets
-44.82%
-11.77%
Return on equity
-51.71%
-14.78%
Earnings Date
Last Earnings Date
Nov
14
Next Earnings Date
May
7
Estimated Next Earnings Date
Feb
13
Balance Sheet
CYCN
Sector
Total cash
$2.9M
$47M
Short term investments
--
$45.2M
Total assets
$13.4M
$142.6M
Long term debt
--
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
